Sullivan Eddie Joe 13D and 13G filings for SAB Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-01 4:55 pm Purchase | 2021-10-22 | 13D | SAB Biotherapeutics, Inc. SABS | Sullivan Eddie Joe | 570,511 13.120% | 570,511 (New Position) | Filing |